Showing 1 - 2 results of 2 for search 'Tatsuya Shimomura', query time: 0.02s
Refine Results
-
1
-
2
Initial dose reduction of enzalutamide does not decrease the incidence of adverse events in castration-resistant prostate cancer. by Shunsuke Tsuzuki, Shotaro Nakanishi, Mitsuyoshi Tamaki, Takuma Oshiro, Jun Miki, Hiroki Yamada, Tatsuya Shimomura, Takahiro Kimura, Nozomu Furuta, Seiichi Saito, Shin Egawa
Published 2021-01-01
Article